Table of Contents Author Guidelines Submit a Manuscript
Journal of Applied Mathematics
Volume 2014 (2014), Article ID 363109, 9 pages
http://dx.doi.org/10.1155/2014/363109
Research Article

Optimal Finite Cancer Treatment Duration by Using Mixed Vaccine Therapy and Chemotherapy: State Dependent Riccati Equation Control

Mechanical Engineering, Center of Excellence in Robotics and Control, KNTU, Pardis Street, Vanak Square, Tehran 16569 83911, Iran

Received 21 November 2013; Revised 28 January 2014; Accepted 2 February 2014; Published 13 March 2014

Academic Editor: Zhijun Liu

Copyright © 2014 Ali Ghaffari et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. W. Swan, “Role of optimal control theory in cancer chemotherapy,” Mathematical Biosciences, vol. 101, no. 2, pp. 237–284, 1990. View at Publisher · View at Google Scholar · View at Scopus
  2. S. T. R. Pinho, H. I. Freedman, and F. Nani, “A chemotherapy model for the treatment of cancer with metastasis,” Mathematical and Computer Modelling, vol. 36, no. 7-8, pp. 773–803, 2002. View at Publisher · View at Google Scholar · View at Zentralblatt MATH · View at MathSciNet
  3. R. Eftimie, J. L. Bramson, and D. J. D. Earn, “Interactions between the immune system and cancer: a brief review of non-spatial mathematical models,” Bulletin of Mathematical Biology, vol. 73, no. 1, pp. 2–32, 2011. View at Publisher · View at Google Scholar · View at Zentralblatt MATH · View at MathSciNet
  4. H. Moradi, G. Vossoughi, and H. Salarieh, “Optimal robust control of drug delivery in cancer chemotherapy: a comparison between three control approaches,” Computer Methods and Programs in Biomedicine, vol. 112, pp. 69–83, 2013. View at Google Scholar
  5. M. Itik, M. U. Salamci, and S. P. Banks, “SDRE optimal control of drug administration in cancer treatment,” Turkish Journal of Electrical Engineering and Computer Sciences, vol. 18, no. 5, pp. 715–729, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Shi, O. Alagoz, F. S. Erenay, and Q. Su, “A survey of optimization models on cancer chemotherapy treatment planning,” Annals of Operations Research, vol. 10, pp. 1–26, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. G. W. Swan and T. L. Vincent, “Optimal control analysis in the chemotherapy of IgG multiple myeloma,” Bulletin of Mathematical Biology, vol. 39, no. 3, pp. 317–337, 1977. View at Google Scholar · View at Scopus
  8. S. E. Clare, F. Nakhlis, and J. C. Panetta, “Molecular biology of breast cancer metastasis. The use of mathematical models to determine relapse and to predict response to chemotherapy in breast cancer,” Breast Cancer Research, vol. 2, no. 6, pp. 430–435, 2000. View at Publisher · View at Google Scholar · View at Scopus
  9. R. S. Parker and F. J. Doyle III, “Control-relevant modeling in drug delivery,” Advanced Drug Delivery Reviews, vol. 48, no. 2-3, pp. 211–228, 2001. View at Publisher · View at Google Scholar · View at Scopus
  10. J. M. Harrold, Model-based design of cancer chemotherapy treatment schedules [Ph.D. thesis], University of Pittsburgh, Pittsburgh, Pa, USA, 2005.
  11. J. M. Harrold and R. S. Parker, “Clinically relevant cancer chemotherapy dose scheduling via mixed-integer optimization,” Computers and Chemical Engineering, vol. 33, no. 12, pp. 2042–2054, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Nanda, H. Moore, and S. Lenhart, “Optimal control of treatment in a mathematical model of chronic myelogenous leukemia,” Mathematical Biosciences, vol. 210, no. 1, pp. 143–156, 2007. View at Publisher · View at Google Scholar · View at Zentralblatt MATH · View at MathSciNet
  13. V. Kumar, R. S. Cotran, and S. L. Robbins, Robbins Basic Pathology, WB Saunders, Philadelphia, Pa, USA, 7th edition, 2003.
  14. C. A. Klein and D. Hölzel, “Systemic cancer progression and tumor dormancy: mathematical models meet single cell genomics,” Cell Cycle, vol. 5, no. 16, pp. 1788–1798, 2006. View at Google Scholar · View at Scopus
  15. H. I. Freedman and S. T. R. Pinho, “Stability criteria for the cure state in a cancer model wtih radiation treatment,” Nonlinear Analysis: Real World Applications, vol. 10, no. 5, pp. 2709–2715, 2009. View at Publisher · View at Google Scholar · View at MathSciNet
  16. L. G. de Pillis, W. Gu, and A. E. Radunskaya, “Mixed immunotherapy and chemotherapy of tumors: modeling, applications and biological interpretations,” Journal of Theoretical Biology, vol. 238, no. 4, pp. 841–862, 2006. View at Publisher · View at Google Scholar · View at MathSciNet
  17. R. K. Sachs, L. R. Hlatky, and P. Hahnfeldt, “Simple ODE models of tumor growth and anti-angiogenic or radiation treatment,” Mathematical and Computer Modelling, vol. 33, no. 12-13, pp. 1297–1305, 2001. View at Publisher · View at Google Scholar · View at Zentralblatt MATH · View at MathSciNet
  18. X. Wei and C. Guo, “Global existence for a mathematical model of the immune response to cancer,” Nonlinear Analysis: Real World Applications, vol. 11, no. 5, pp. 3903–3911, 2010. View at Publisher · View at Google Scholar · View at Zentralblatt MATH · View at MathSciNet
  19. Y. Hirata, N. Bruchovsky, and K. Aihara, “Development of a mathematical model that predicts the outcome of hormone therapy for prostate cancer,” Journal of Theoretical Biology, vol. 264, no. 2, pp. 517–527, 2010. View at Publisher · View at Google Scholar · View at MathSciNet
  20. Y. Kuang, J. D. Nagy, and J. J. Elser, “Biological stoichiometry of tumor dynamics: mathematical models and analysis,” Discrete and Continuous Dynamical Systems B, vol. 4, no. 1, pp. 221–240, 2004. View at Google Scholar · View at Zentralblatt MATH · View at MathSciNet
  21. A. Ghaffari and N. Naserifar, “Optimal therapeutic protocols in cancer immunotherapy,” Computers in Biology and Medicine, vol. 40, no. 3, pp. 261–270, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. K. R. Fister and J. C. Panetta, “Optimal control applied to cell-cycle-specific cancer chemotherapy,” SIAM Journal on Applied Mathematics, vol. 60, no. 3, pp. 1059–1072, 2000. View at Publisher · View at Google Scholar · View at Zentralblatt MATH · View at MathSciNet
  23. L. G. de Pillis and A. Radunskaya, “A mathematical tumor model with immune resistance and drug therapy: an optimal control approach,” Journal of Theoretical Medicine, vol. 3, no. 2, pp. 79–100, 2001. View at Google Scholar · View at Scopus
  24. L. G. de Pillis, W. Gu, K. R. Fister et al., “Chemotherapy for tumors: an analysis of the dynamics and a study of quadratic and linear optimal controls,” Mathematical Biosciences, vol. 209, no. 1, pp. 292–315, 2007. View at Publisher · View at Google Scholar · View at Zentralblatt MATH · View at MathSciNet
  25. L. G. de Pillis and A. Radunskaya, “The dynamics of an optimally controlled tumor model: a case study,” Mathematical and Computer Modelling, vol. 37, no. 11, pp. 1221–1244, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Itik, M. U. Salamci, and S. P. Banks, “Optimal control of drug therapy in cancer treatment,” Nonlinear Analysis: Theory, Methods and Applications, vol. 71, no. 12, pp. e1473–e1486, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. Y. Batmani and H. Khaloozadeh, “Optimal chemotherapy in cancer treatment: state dependent Riccati equation control and extended Kalman filter,” Optimal Control Applications & Methods, vol. 34, no. 5, pp. 562–577, 2013. View at Publisher · View at Google Scholar · View at MathSciNet
  28. A. K. Abbas and A. H. Lichtman, Basic Immunology: Functions and Disorders of the Immune System, Elsevier—Health Sciences Division, Philadelphia, Pa, USA, 3rd edition, 2010.